{"id":651,"date":"2024-11-20T10:59:39","date_gmt":"2024-11-20T01:59:39","guid":{"rendered":"https:\/\/cichlid.tech\/?post_type=contents&p=651"},"modified":"2024-11-20T10:59:39","modified_gmt":"2024-11-20T01:59:39","slug":"deep-bio-and-pathai-collaborate-to-drive-ai-powered-innovations-in-digital-pathology-integrating-deep-bios-deepdx-prostate-algorithm-into-pathais-aisight-ims-platform","status":"publish","type":"contents","link":"https:\/\/cichlid.tech\/en\/contents\/deep-bio-and-pathai-collaborate-to-drive-ai-powered-innovations-in-digital-pathology-integrating-deep-bios-deepdx-prostate-algorithm-into-pathais-aisight-ims-platform\/","title":{"rendered":"Deep Bio and PathAI Collaborate to Drive AI-Powered Innovations in Digital Pathology \u2013 Integrating Deep Bio\u2019s DeepDx Prostate Algorithm into PathAI\u2019s AISight IMS Platform"},"content":{"rendered":"

Deep Bio “This collaboration allows broader access to our AI-driven diagnostic tools”\n<\/p><\/blockquote>\n

[by Kang, In Hyo] Deep Bio, a leader in artificial intelligence for digital pathology, announced on November 20 a collaboration to integrate its prostate cancer analysis solution, DeepDx Prostate, with PathAI\u2019s AISight\u00ae1 Image Management System (IMS). This collaboration combines Deep Bio\u2019s clinically validated AI technology with PathAI\u2019s advanced digital pathology platform, expanding access to powerful diagnostic tools for prostate cancer.<\/p>\n

DeepDx Prostate, which is CE-marked and clinically validated, provides AI-supported diagnostics for prostate cancer by analyzing digitized slide images of Hematoxylin & Eosin (H&E) stained prostate specimens. The software classifies each lesion by histological type or risk grade, measures lesion size, and generates metrics crucial for cancer diagnosis, prognosis, and treatment planning, including lesion type proportions and overall tissue lesion ratios.<\/p>\n

PathAI, the developer of the AISight IMS platform, is a pioneering provider of AI-powered research tools and services for pathology, working with leading life sciences companies, laboratories, and researchers to advance precision medicine. AISight is a complete solution for primary diagnosis, centralizing case and image management in a cloud-native, intelligent platform. It provides pathologists with an intuitive way to view, interpret, share, and manage whole slide images, enhancing both confidence and efficiency in diagnostic workflows. Ideal for clinical settings of all sizes\u2014from individual labs to large hospital networks\u2014AISight is utilized by premier laboratories and research centers globally to streamline digital pathology workflows and AI applications, serving as a central hub equipped with top-tier AI tools for multiple histopathology applications.<\/p>\n

\u201cWe are thrilled to integrate DeepDx Prostate with PathAI\u2019s AISight IMS platform,\u201d said Deep Bio CEO Sun Woo Kim. \u201cThis collaboration allows broader access to our AI-driven diagnostic tools, and we aim to transform prostate cancer diagnostics by empowering clinicians with advanced tools to guide treatment decisions.\u201d<\/p>\n

“We are excited to welcome Deep Bio\u2019s DeepDx Prostate algorithm into the AISight platform,” said Andy Beck, CEO of PathAI. “This collaboration exemplifies our commitment to equipping pathologists with cutting-edge tools that enhance precision and increase workflow efficiency. By expanding the reach of advanced AI solutions, we continue to make meaningful strides in improving patient outcomes and transforming digital pathology on a global scale.”<\/p>\n

Leveraging PathAI\u2019s rapidly growing install base of AISight users, through this integration, DeepDx Prostate will reach a wider range of clinicians and patients across North America and Europe, providing access to leading-edge diagnostic tools for prostate cancer. This collaboration marks a pivotal step toward Deep Bio\u2019s vision of advancing AI-powered cancer diagnostics on a global scale.<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","contents-tax":[10],"acf":[],"_links":{"self":[{"href":"https:\/\/cichlid.tech\/en\/wp-json\/wp\/v2\/contents\/651"}],"collection":[{"href":"https:\/\/cichlid.tech\/en\/wp-json\/wp\/v2\/contents"}],"about":[{"href":"https:\/\/cichlid.tech\/en\/wp-json\/wp\/v2\/types\/contents"}],"wp:attachment":[{"href":"https:\/\/cichlid.tech\/en\/wp-json\/wp\/v2\/media?parent=651"}],"wp:term":[{"taxonomy":"contents-tax","embeddable":true,"href":"https:\/\/cichlid.tech\/en\/wp-json\/wp\/v2\/contents-tax?post=651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}